Invasive micropapillary carcinoma of the breast
Prepared with OnCo (onco.cc/prep/invasive-micropapillary-carcinoma-breast/). Orientation, not medical advice; your team knows your case.
My details
What I know, what is unclear, changes to discuss
Saved in this browserMy questions
7 on the sheet- 1.What is my exact diagnosis, stage, and grade, and which tests established them?
- 2.Which biomarkers have been tested on my tumour (for example Inside-out EMA or MUC1 staining, Oestrogen and progesterone receptor, HER2, Lymphovascular invasion and node status), and what were the results?
- 3.Which subtype is my cancer, and does that change the recommended treatment?
- 4.Is germline (inherited) genetic testing recommended for me or my family?
- 5.For my situation (all stages), which of the standard options do you recommend and why?
- 6.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
- 7.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
Tests and results to bring
Biomarker results to ask for: Inside-out EMA or MUC1 staining, Oestrogen and progesterone receptor (usually positive), HER2 (positive in a proportion), Lymphovascular invasion and node status.
Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.
The treatments I may be offered
- All stages: Treated by receptor status on the parent's pages, with careful axillary staging. (HR-positive / HER2-negative breast cancer, HER2-positive breast cancer, Endocrine therapy (SERMs, AIs, SERDs))
From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.